NNOX
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Valuation is based on speculative future growth rather than current fundamentals.
- P/B ratio near 1.0
- P/S ratio of 13.97 is excessive for current profitability
- No Graham Number available due to lack of earnings
Growth is present in revenue but not translating to the bottom line.
- Consistent revenue growth
- Aggressive analyst price targets
- No clear path to profitability given current margin structure
- Negative forward P/E
Historical price performance is overwhelmingly bearish.
- Some recent EPS beats
- 92.8% loss in value over 5 years
- Consistent quarterly losses
Balance sheet is healthy, but the business model is currently value-destructive.
- Piotroski F-Score 4/9 (Stable)
- Low debt levels
- High Quick Ratio (3.80)
- Negative ROE and ROA
- High operational burn rate
Company is in a growth/burn phase.
- No dividend paid
- No history of payouts
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for NNOX and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
NNOX
Nano-X Imaging Ltd.
Primary
|
-92.8% | -63.4% | -47.9% | -40.0% | -4.6% | +7.4% |
|
PDEX
Pro-Dex, Inc.
Peer
|
+100.7% | +227.7% | -14.2% | +120.0% | +5.2% | +3.4% |
|
INGN
Inogen, Inc.
Peer
|
-88.6% | -52.4% | -10.6% | -22.4% | +1.6% | +1.9% |
|
LFMD
LifeMD, Inc.
Peer
|
-74.2% | +107.8% | -30.3% | -43.8% | -14.5% | -1.1% |
|
LFCR
Lifecore Biomedical, Inc.
Peer
|
-52.8% | +24.4% | -17.0% | -26.9% | -30.2% | +23.7% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q3 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
NNOX
Nano-X Imaging Ltd.
|
BEARISH | $171.89M | - | -34.8% | -% | $2.47 | |
|
PDEX
Pro-Dex, Inc.
|
BULLISH | $171.58M | 15.43 | 30.9% | 15.7% | $52.6 | Compare |
|
INGN
Inogen, Inc.
|
BEARISH | $172.38M | - | -12.4% | -6.5% | $6.33 | Compare |
|
LFMD
LifeMD, Inc.
|
BEARISH | $166.47M | - | -131.2% | 7.4% | $3.47 | Compare |
|
LFCR
Lifecore Biomedical, Inc.
|
BEARISH | $178.02M | - | -% | -23.8% | $4.75 | Compare |
Wall Street Analysts
Professional analyst ratings and price targets
Past News Coverage
Recent headlines mentioning NNOX from our newsroom.